Organization
Portola Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Portola Pharmaceuticals, Inc.
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received FDA approval for its NOAC Betrixaban in July 2017) are ...
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC-Betrixaban in July 2017) are ...
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC-Betrixaban in July 2017) are ...
... SOUTH SAN FRANCISCO, Calif. - Portola Pharmaceuticals Inc. (Nasdaq: PTLA) today announced that results of new sub-analyses of the APEX ...
... SOUTH SAN FRANCISCO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) will today report financial results and provide a corporate update ...
... as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC Betrixaban in July 2017) ...
... SOUTH SAN FRANCISCO, Calif., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that Bill Lis, chief executive officer, will present at ...
... SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that it will host a webcast and conference ...
... Â 17Â The Priceline Group, Inc. (14) 1.3 % Â 18Â Portola Pharmaceuticals, Inc. (8) 1.3 % Â 19Â Ecolab, Inc. (13) 1.3 % Â ...
... SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) announced today that it will be serving as a global ...
... SOUTH SAN FRANCISCO, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on September 27, 2017, the Compensation Committee ...
... Curnutte is currently the executive vice president of research and development at Portola Pharmaceuticals. At Portola, Dr. Curnutte oversees all of the company's R&D operations, ...
... If you want a Stock Review on OPK, OTIC, PACB, or PTLA then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report. Zacks ...
... 1.5 % Â 7 Salesforce.com, Inc. (14) 1.4 % Â 8 Portola Pharmaceuticals, Inc. (16) 1.4 % Â 9 Facebook, Inc., Class A (8) 1.4 ...
... SOUTH SAN FRANCISCO, Calif., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) announced today the pricing of its underwritten public offering of ...
... Prongay & Murray LLP ("GPM") announces an investigation on behalf of Portola Pharmaceuticals, Inc. ("Portola" or the "Company") (NASDAQ: PTLA ) investors concerning the Company ...
... it has entered into a long term commercial supply agreement with Portola Pharmaceuticals, Inc., a biopharmaceutical company developing product candidates that could significantly advance the ...
... SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that Bill Lis, chief executive officer, will present at ...
... SOUTH SAN FRANCISCO, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) announced that it will host a webcast and conference call to ...
... SOUTH SAN FRANCISCO - Portola Pharmaceuticals Inc. (Nasdaq: PTLA) today announced that data on betrixaban and andexanet alfa, as ...
... (17) 1.3% 15 Â FleetCor Technologies, Inc. (19) 1.3% 16 Â Portola Pharmaceuticals, Inc. (16) 1.3% 17 Â Alphabet, Inc., Class C (15) 1.3% 18 ...
... SOUTH SAN FRANCISCO, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA) ...
... SOUTH SAN FRANCISCO, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today reported financial results and provided a corporate update for ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤